Direxion Daily Pharmaceutical & Medical Bull 3X Shares Rating $5.55 +0.28 (+5.31%) Closing price 05/2/2025 04:10 PM EasternExtended Trading$5.54 -0.01 (-0.27%) As of 05/2/2025 05:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock Direxion Daily Pharmaceutical & Medical Bull 3X Shares Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PILL Aggregate RatingModerate Buy 2.69Holdings in PILL have an aggregate rating of Moderate Buy based on 370 analyst ratings issued in the past year covering 42 companies (81.5% of the portfolio).PILL Aggregate Price Target$5.55High Prediction$5.55Average Prediction$5.55Low Prediction$5.55Holdings in PILL have an aggregate price target of $5.55 and a range of $5.55 to $5.55 covering 42 companies (81.5% of the portfolio).PILL Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy20 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily Pharmaceutical & Medical Bull 3X Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 42 PILL Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.42%CORTCorcept Therapeutics$72.77+1.8%4.8075 of 5 stars3.00$143.25 96.9%5Upcoming EarningsShort Interest ↓News CoveragePositive News3.44%RPRXRoyalty Pharma$32.89+1.3%4.2909 of 5 stars3.00$42.50 29.2%5Upcoming EarningsPositive News3.32%TARSTarsus Pharmaceuticals$47.36-5.8%2.1074 of 5 stars3.00$64.67 36.5%7Earnings ReportUpcoming EarningsAnalyst ForecastNews CoveragePositive NewsGap Down3.31%PBHPrestige Consumer Healthcare$84.23+2.4%4.0869 of 5 stars2.50$93.33 10.8%6Upcoming EarningsAnalyst UpgradeNews Coverage3.30%JNJJohnson & Johnson$156.09+1.1%4.7185 of 5 stars2.63$171.82 10.1%19Analyst Revision3.28%ZTSZoetis$157.43+1.1%4.5453 of 5 stars3.08$214.40 36.2%12Upcoming EarningsPositive News3.17%PRGOPerrigo$25.65+1.5%4.8779 of 5 stars2.25$33.00 28.7%4Upcoming EarningsDividend AnnouncementShort Interest ↑Positive News3.13%LLYEli Lilly and Company$825.10+3.9%4.9397 of 5 stars2.81$1,002.80 21.5%21Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap Up3.02%PFEPfizer$24.19+1.1%4.9849 of 5 stars2.53$29.17 20.6%15Earnings ReportAnalyst ForecastAnalyst Revision3.00%MRKMerck & Co., Inc.$83.14-0.1%5 of 5 stars2.59$111.13 33.7%22Insider TradeAnalyst RevisionPositive News3.00%BMYBristol-Myers Squibb$50.56+1.9%4.7048 of 5 stars2.32$58.00 14.7%22Insider TradeAnalyst Revision2.94%ELANElanco Animal Health$9.75+2.9%4.0783 of 5 stars2.43$14.67 50.5%7Upcoming EarningsShort Interest ↑2.91%AXSMAxsome Therapeutics$112.210.0%4.8479 of 5 stars3.00$169.87 51.4%16Upcoming EarningsAnalyst ForecastShort Interest ↓Analyst RevisionNews CoveragePositive News2.89%VTRSViatris$8.65+2.1%1.5987 of 5 stars1.75$10.50 21.4%4Upcoming EarningsGap Up2.69%PCRXPacira BioSciences$26.45-1.1%1.9835 of 5 stars2.33$26.67 0.8%9Upcoming Earnings2.65%JAZZJazz Pharmaceuticals$120.05+2.4%4.8369 of 5 stars2.93$187.71 56.4%14Upcoming EarningsAnalyst RevisionNews Coverage2.64%OGNOrganon & Co.$9.60+1.6%4.7313 of 5 stars2.00$19.67 104.9%4Earnings ReportDividend CutAnalyst DowngradeOptions VolumeNews CoverageHigh Trading Volume2.39%HRMYHarmony Biosciences$30.32+1.5%4.8628 of 5 stars3.00$52.44 73.0%9Upcoming EarningsAnalyst RevisionNews CoverageGap Up2.13%AMPHAmphastar Pharmaceuticals$24.50+2.6%4.4117 of 5 stars2.00$43.50 77.6%3Upcoming EarningsNews CoveragePositive News1.90%ARVNArvinas$7.72+6.8%3.3103 of 5 stars2.63$25.82 234.5%19Earnings ReportAnalyst ForecastShort Interest ↑News CoverageHigh Trading Volume1.87%SUPNSupernus Pharmaceuticals$32.84+1.2%2.4569 of 5 stars2.33$36.00 9.6%3Upcoming Earnings1.86%ANIPANI Pharmaceuticals$72.95+3.2%3.9109 of 5 stars3.00$80.13 9.8%9Upcoming EarningsPositive News1.57%LGNDLigand Pharmaceuticals$109.39+0.2%4.4159 of 5 stars3.00$146.43 33.9%7Upcoming EarningsPositive News1.57%HROWHarrow$25.83+3.3%2.2899 of 5 stars3.00$60.50 134.2%4Positive News1.52%EWTXEdgewise Therapeutics$16.91+1.4%2.9784 of 5 stars2.78$40.22 137.9%9Upcoming EarningsAnalyst ForecastShort Interest ↑News CoveragePositive News1.45%COLLCollegium Pharmaceutical$27.65+2.2%3.9808 of 5 stars2.80$43.60 57.7%5Upcoming EarningsNews CoveragePositive News1.44%LQDALiquidia$15.83+13.2%2.908 of 5 stars3.11$26.63 68.2%9News CoveragePositive NewsHigh Trading Volume1.34%INVAInnoviva$18.72+0.4%4.2306 of 5 stars3.00$55.00 193.8%2Upcoming EarningsAnalyst UpgradeNews CoveragePositive News1.06%AMRXAmneal Pharmaceuticals$7.97+3.0%3.3369 of 5 stars3.00$10.80 35.5%5Earnings ReportNews CoveragePositive NewsHigh Trading Volume0.86%OCULOcular Therapeutix$8.80+3.2%3.6286 of 5 stars2.89$16.38 86.1%9Upcoming EarningsNews CoveragePositive News0.81%WVEWave Life Sciences$8.10+2.0%4.3159 of 5 stars3.00$21.17 161.3%12Upcoming EarningsAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume0.81%MNMDMind Medicine (MindMed)$6.93+5.2%2.4339 of 5 stars3.23$25.11 262.4%13Upcoming EarningsNews CoveragePositive NewsGap Up0.76%EOLSEvolus$12.08+2.4%3.8642 of 5 stars3.00$23.75 96.6%5Upcoming EarningsAnalyst RevisionPositive News0.73%CRMDCorMedix$9.38-2.8%2.519 of 5 stars3.14$14.50 54.6%7Upcoming EarningsPositive News0.68%NUVBNuvation Bio$2.46+8.4%3.6379 of 5 stars3.17$7.83 218.4%6Upcoming EarningsNews CoverageHigh Trading Volume0.68%XERSXeris Biopharma$4.71+5.1%3.5556 of 5 stars2.80$6.10 29.5%5Upcoming EarningsNews CoveragePositive News0.64%OMEROmeros$7.17+2.1%3.7457 of 5 stars2.80$22.50 213.8%5Positive News0.56%EYPTEyePoint Pharmaceuticals$7.30+2.4%1.7397 of 5 stars3.00$26.63 264.7%9Upcoming EarningsNews CoveragePositive News0.48%ELVNEnliven Therapeutics$20.51+3.3%2.3488 of 5 stars3.25$40.33 96.7%4News Coverage0.45%ESPREsperion Therapeutics$1.09+10.8%3.6044 of 5 stars2.50$6.42 488.7%6Upcoming EarningsAnalyst RevisionNews Coverage0.41%PAHCPhibro Animal Health$19.48+4.7%3.3649 of 5 stars1.50$19.75 1.4%4Upcoming EarningsPositive News0.39%ZVRAZevra Therapeutics$8.00+4.7%2.8015 of 5 stars3.11$22.29 178.6%9Upcoming EarningsNews CoveragePositive News This page (NYSEARCA:PILL) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily Pharmaceutical & Medical Bull 3X Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily Pharmaceutical & Medical Bull 3X Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PILL Stock Free PILL Stock Alerts